Sangamo Therapeutics
-$0.01 (-0.09%) As of 1:06 PM UTC pre-market
Why Robinhood?
You can buy or sell SGMO and other stocks, options, and ETFs commission-free!
About SGMO
Sangamo Therapeutics, Inc. Common Stock, also called Sangamo Therapeutics, is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins.
CEO
Alexander D. Macrae
Employees
413
Headquarters
Brisbane, California
Founded
1995
SGMO Key Statistics
Market Cap
1.69B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
872.50K
High Today
$11.90
Low Today
$11.62
Open Price
$11.78
Volume
564.22K
52 Week High
$19.43
52 Week Low
$8.51
Analyst Ratings
67%
of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
SGMO Earnings
-$0.37
-$0.23
-$0.10
$0.04
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 3, After Hours